Get my own profile
Public access
View all25 articles
1 article
available
not available
Based on funding mandates
Co-authors
- thomas A waldmannChief Lymphoid Malignancies Branch National Cancer Institute NIHVerified email at helix.nih.gov
- Wyndham WilsonNational Cancer InstituteVerified email at mail.nih.gov
- Christopher MelaniNational Cancer InstituteVerified email at nih.gov
- Elaine JaffeNational Cancer InstituteVerified email at mail.nih.gov
- Vinay Prasad, MD MPHProfessor, University of California San FranciscoVerified email at ucsf.edu
- Murali JanakiramAssistant professor, Albert Einstein College of Medicine and Montefiore Medical CenterVerified email at montefiore.org
- rahul lakhotiaStaff Clinician, Lymphoid Malignancies Branch, National Cancer InstituteVerified email at nih.gov
- Mario RoedererVaccine Research Center, NIAID, NIHVerified email at nih.gov
- William Douglas Figg, SrNational Cancer InstituteVerified email at mail.nih.gov
- Louis M. StaudtNational Cancer InstituteVerified email at mail.nih.gov
- Jagan MuppidiNational Institutes of HealthVerified email at nih.gov
- Timothée OLIVIERGeneva University HospitalVerified email at hug.ch
- Alyson HaslamUniversity of California San FranciscoVerified email at ucsf.edu
- James D PhelanStaff Scientist, National Cancer InstituteVerified email at nih.gov
- Anusara DaenthanasanmakNational Cancer Institute/NIHVerified email at nih.gov
- Jordan TuiaUniversity of California San FranciscoVerified email at ucsf.edu
- Chou-Zen GiamUniformed Services UniversityVerified email at usuhs.edu
- Erik C. YuskoAdaptive BiotechnologiesVerified email at adaptivebiotech.com
- Susannah G. EllsworthAssociate Professor of Radiation Oncology, University of Pittsburgh Hillman Cancer CenterVerified email at upmc.edu
- Christopher M. JewellUniversity of Maryland - College ParkVerified email at umd.edu